DE69607597T2 - Benzol-derivate - Google Patents

Benzol-derivate

Info

Publication number
DE69607597T2
DE69607597T2 DE69607597T DE69607597T DE69607597T2 DE 69607597 T2 DE69607597 T2 DE 69607597T2 DE 69607597 T DE69607597 T DE 69607597T DE 69607597 T DE69607597 T DE 69607597T DE 69607597 T2 DE69607597 T2 DE 69607597T2
Authority
DE
Germany
Prior art keywords
group
benzene derivatives
pharmacologically acceptable
formula
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69607597T
Other languages
German (de)
English (en)
Other versions
DE69607597D1 (de
Inventor
Naoki Hase
Masaichi Hasegawa
Takashi Kamimura
Katsushi Takahashi
Takumi Takeyasu
Naoki Tsuchiya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of DE69607597D1 publication Critical patent/DE69607597D1/de
Application granted granted Critical
Publication of DE69607597T2 publication Critical patent/DE69607597T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/38—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69607597T 1995-11-27 1996-11-26 Benzol-derivate Expired - Fee Related DE69607597T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP30722295 1995-11-27
JP22836796 1996-08-29
PCT/JP1996/003456 WO1997019910A1 (en) 1995-11-27 1996-11-26 Benzene derivatives

Publications (2)

Publication Number Publication Date
DE69607597D1 DE69607597D1 (de) 2000-05-11
DE69607597T2 true DE69607597T2 (de) 2000-08-24

Family

ID=26528211

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69607597T Expired - Fee Related DE69607597T2 (de) 1995-11-27 1996-11-26 Benzol-derivate

Country Status (12)

Country Link
US (1) US5808144A (cg-RX-API-DMAC7.html)
EP (1) EP0806412B1 (cg-RX-API-DMAC7.html)
JP (1) JP3117466B2 (cg-RX-API-DMAC7.html)
KR (1) KR100309754B1 (cg-RX-API-DMAC7.html)
CN (1) CN1081623C (cg-RX-API-DMAC7.html)
AT (1) ATE191458T1 (cg-RX-API-DMAC7.html)
AU (1) AU703092B2 (cg-RX-API-DMAC7.html)
CA (1) CA2210579C (cg-RX-API-DMAC7.html)
DE (1) DE69607597T2 (cg-RX-API-DMAC7.html)
ES (1) ES2144786T3 (cg-RX-API-DMAC7.html)
TW (1) TW346483B (cg-RX-API-DMAC7.html)
WO (1) WO1997019910A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100682276B1 (ko) 1998-07-24 2007-02-28 데이진 가부시키가이샤 안트라닐산 유도체
US6627743B1 (en) * 1999-12-03 2003-09-30 Abbott Laboratories 6-O-methylerythromycin A crystal form III
AU2001234089B2 (en) * 2000-02-15 2005-08-11 Teijin Limited Cancer remedy comprising anthranilic acid derivative as active ingredient
GB0319124D0 (en) * 2003-08-14 2003-09-17 Smithkline Beecham Corp Chemical compounds
WO2020252195A1 (en) * 2019-06-11 2020-12-17 The Wistar Institute Of Anatomy And Biology Telomerase reverse transcriptase degraders and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE736787A (fr) * 1968-08-02 1970-01-30 Roussel Uclaf Dérivés de l'acide anthranilique et procédé de préparation
JPS60116657A (ja) * 1983-11-30 1985-06-24 Ono Pharmaceut Co Ltd アニリン誘導体
WO1993015043A1 (fr) * 1992-01-24 1993-08-05 Yoshitomi Pharmaceutical Industries, Ltd. Compose arylalkananilide et utilisation pharmaceutique
US5783593A (en) 1993-11-04 1998-07-21 Abbott Laboratories Inhibitors of squalene synthetase and protein farnesyltransferase

Also Published As

Publication number Publication date
US5808144A (en) 1998-09-15
EP0806412A4 (cg-RX-API-DMAC7.html) 1997-11-12
ATE191458T1 (de) 2000-04-15
TW346483B (en) 1998-12-01
CA2210579A1 (en) 1997-06-05
JP3117466B2 (ja) 2000-12-11
ES2144786T3 (es) 2000-06-16
EP0806412B1 (en) 2000-04-05
CA2210579C (en) 2003-03-11
KR19980701699A (ko) 1998-06-25
CN1173169A (zh) 1998-02-11
DE69607597D1 (de) 2000-05-11
EP0806412A1 (en) 1997-11-12
WO1997019910A1 (en) 1997-06-05
CN1081623C (zh) 2002-03-27
AU7590296A (en) 1997-06-19
KR100309754B1 (ko) 2002-05-30
AU703092B2 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
DE3875782T2 (de) Leucotrien-antagonisten.
DE69429591T2 (de) Therapeutisch wirksame Verbindungen
CH645625A5 (de) Benzoesaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel.
DE69512777T2 (de) Naphthalinderivate
DE69107959T2 (de) 3-Cycloalkylpropansäureamide, ihre Tautomere und Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und sie enthaltende Zusammensetzungen.
DE69920923T2 (de) Anthranilsäurederivate
DE10046029A1 (de) Indazole
DE69718968T2 (de) 3-(bis-substituierte-phenylmethylen)oxindol-derivate
DE69014798T2 (de) Thionaphthalen-derivate, verfahren zur herstellung und antiallergisches mittel daraus.
EP0261478B1 (de) Neue Derivate von 4,5-Dihydro-oxazolen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE102005023588A1 (de) Salze substituierter Allophansäureester und deren Verwendung in Arzneimitteln
LV10618B (en) A novel derivatives of thienothiazine, method for preparing thereof and use
CH631973A5 (de) Verfahren zur herstellung von benzimidazolderivaten.
DE69110217T2 (de) Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen.
DE3781703T2 (de) 2-benzimidazolylalkylthio(oder sulfinyl- oder sulfonyl)-derivate, verfahren zu deren herstellung und deren anwendung als arzneimittel.
DE2944293A1 (de) Alpha , alpha , alpha -trifluor- (aminoaryl)-aethanole, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2431292A1 (de) Neue carbazol-derivate
DE2427272C3 (de) 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum
JP3117466B2 (ja) ベンゼン誘導体
DE69131353T2 (de) Indolderivate
DE2923698A1 (de) Substituierte aminoalkansaeuren, ihre verwendung und herstellung und sie enthaltende arzneimittel
EP0156091B1 (de) Beta-Oxo-alpha-carbamoyl-pyrrolpropionitrile, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
JPWO1997019910A1 (ja) ベンゼン誘導体
EP0525686A1 (de) Dimethylacetessigsäureamide, Verfahren zu ihrer Herstellung und Arzneimittel
EP0289881A2 (de) Neue 2-Aminoalkyl-4-bennzyl-1-(2H)-phthalazinon-Derivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee